| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/13/2001 | WO2001066740A2 Compositions and methods for the treatment of immune related diseases |
| 09/13/2001 | WO2001066739A1 çDNA ENCODING A TRAG GENE (TGF- β RESISTANCE ASSOCIATED GENE) AND ITS PROTEIN PRODUCT |
| 09/13/2001 | WO2001066738A2 Nucleic acids, encoding human crsp1 and uses thereof |
| 09/13/2001 | WO2001066737A1 Polypeptide inducing apoptosis |
| 09/13/2001 | WO2001066736A1 Proteins nectin-3 |
| 09/13/2001 | WO2001066735A1 Mitf-associated proteins |
| 09/13/2001 | WO2001066734A1 Polypeptides having activity of stimulating neutrophils |
| 09/13/2001 | WO2001066733A1 Nucleic acid sequences showing enhanced expression in benign neuroblastoma compared with acritical human neuroblastoma |
| 09/13/2001 | WO2001066732A1 Human abc transporter expressed in liver, atil |
| 09/13/2001 | WO2001066731A1 A novel polypeptide-human zinc finger protein 32 and the polynucleotide encoding said polypeptide |
| 09/13/2001 | WO2001066730A1 A novel polypeptide, a human rs3 protein 12 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066729A1 A novel polypeptide, a human actin 14 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066728A1 A novel polypeptide, a human dna mismatch repair gene protein 11 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066727A1 A novel polypeptide, a human thyrocalcitonin 15 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066726A1 A novel polypeptide, a human excitatory amino acids transporter 17 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066725A1 A novel polypeptide, an external dynein arms dhc1alpha47 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066724A1 A novel polypeptide, a human actin 14 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066723A2 Hetero-oligomeric g protein-coupled receptors as drug target |
| 09/13/2001 | WO2001066722A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066721A2 Nucleic acid sensor molecules |
| 09/13/2001 | WO2001066720A1 Mouse adipocyte-origin genes |
| 09/13/2001 | WO2001066719A1 Novel gene cloned in human neuroblastoma and novel gene fragments |
| 09/13/2001 | WO2001066718A1 Method for removing endotoxins |
| 09/13/2001 | WO2001066717A2 Gene targeting method |
| 09/13/2001 | WO2001066716A1 Polypeptide having phosphodiesterase activity |
| 09/13/2001 | WO2001066715A2 Rapid generation of recombinant adenoviral vectors |
| 09/13/2001 | WO2001066712A2 Variants with altered properties |
| 09/13/2001 | WO2001066711A1 Xylanase variants having altered sensitivity to xylanase inhibitors |
| 09/13/2001 | WO2001066710A2 Human ribonuclease |
| 09/13/2001 | WO2001066709A2 Sphingomyelinase enzymes and uses relating thereto |
| 09/13/2001 | WO2001066708A2 MATERIALS AND METHODS RELATING TO THE DEGRADATION OF Cdc25A IN RESPONSE TO DNA DAMAGE |
| 09/13/2001 | WO2001066706A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066705A1 Rna polymerase mutants with increased thermostability |
| 09/13/2001 | WO2001066704A2 Methods for making plants tolerant to glyphosate and compositions thereof |
| 09/13/2001 | WO2001066703A1 Production of lutein in microorganisms |
| 09/13/2001 | WO2001066696A2 Stable cell lines resistant to apoptosis and nutrient stress and methods of making same |
| 09/13/2001 | WO2001066694A2 Method for transferring material in a cell system |
| 09/13/2001 | WO2001066693A1 Compositions and methods for producing high yields of heterologous polypeptides in a pichia cell |
| 09/13/2001 | WO2001066690A2 Novel compounds |
| 09/13/2001 | WO2001066599A1 Crystal |
| 09/13/2001 | WO2001066598A2 Chemoattractant receptor characterization and cell selection materials and methods and chemokine receptor ccr11 materials and methods |
| 09/13/2001 | WO2001066597A2 Inflammation-related gene |
| 09/13/2001 | WO2001066595A2 Human fgf-23 gene and gene expression products |
| 09/13/2001 | WO2001066594A2 Human protein kinases and protein kinase-like enzymes |
| 09/13/2001 | WO2001066593A1 Structural coordinate of protein complex and utilization of the structural coordinate |
| 09/13/2001 | WO2001066592A1 A novel polypeptide, human rna helicase 9 and the polynucleotide encoding thereof |
| 09/13/2001 | WO2001066591A1 A novel polypeptide - human receptor-related protein tyrosine phosphatase 11 and a polynucleotide sequence encoding the same |
| 09/13/2001 | WO2001066590A1 A novel polypeptide, human clathrin light chain 14 and the polynucleotide encoding thereof |
| 09/13/2001 | WO2001066589A1 A novel polypeptide, beta transductin 11 and the polynucleotide encoding thereof |
| 09/13/2001 | WO2001066588A1 A novel polypeptide, human interleukin binding factor 1-12 and the polynucleotide encoding thereof |
| 09/13/2001 | WO2001066587A1 A novel polypeptide - human vacuolar proton-adenosine triphosphatase c subunit 9 and a polynucleotide sequence encoding the same |
| 09/13/2001 | WO2001066586A1 A novel polypeptide, human rna helicase 13 and the polynucleotide encoding thereof |
| 09/13/2001 | WO2001066585A1 A new polypeptide-human protease regulatory protein 10 and the p olynucleotide encoding it |
| 09/13/2001 | WO2001066584A1 A novel polypeptide, human pax protein 9 and the polynucleotide encoding thereof |
| 09/13/2001 | WO2001066583A1 A new polypeptide - human zinc finger protein 14 and the polynucleotide encoding it |
| 09/13/2001 | WO2001066582A1 A NEW POLYPEPTIDE-HUMAN ZINC FINGER PROTEIN 27 AND THE POLYNUCLEOTIDE ENCODING It |
| 09/13/2001 | WO2001066581A1 A novel polypeptide, human ribosomal protein s4-19 and the polynucleotide encoding thereof |
| 09/13/2001 | WO2001066580A1 A new polypeptide-human zinc finger protein 13 and the polynucleotide encoding it |
| 09/13/2001 | WO2001066579A1 A new polypeptide- human cytochrome constitutive protein 14 and the polynucleotide encoding it |
| 09/13/2001 | WO2001066578A1 A novel polypeptide-dna polymerase 10 and polynucleotide encoding said polypeptide |
| 09/13/2001 | WO2001066577A1 A novel polypeptide - homo signal transduction protein kinase 17 and polynucleotide encoding said polypeptide |
| 09/13/2001 | WO2001066576A1 A novel polypeptide-homo amyloid 11 and polynucleotide encoding said polypeptide |
| 09/13/2001 | WO2001066575A1 A novel polypeptide, an actin 49 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066573A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 09/13/2001 | WO2001066572A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 09/13/2001 | WO2001066571A1 Therapeutic and prophylactic agents derived from aeromonas hydrophila bacterial surface proteins |
| 09/13/2001 | WO2001066569A1 Viral antigen and vaccine against isav (infectious salmon anaemia virus) |
| 09/13/2001 | WO2001066568A2 Use of recombinant antigens to determine the immune status of an animal |
| 09/13/2001 | WO2001066566A2 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids |
| 09/13/2001 | WO2001066565A2 In vivo production of cyclic peptides |
| 09/13/2001 | WO2001066563A2 T1r taste receptors and genes encoding same |
| 09/13/2001 | WO2001066557A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066556A1 5-pyrimidine-containing nucleic acids and reversible ligation method by using the same |
| 09/13/2001 | WO2001066554A2 Solid phase synthesis method and reagent |
| 09/13/2001 | WO2001066254A1 Reaction system for thermal cycling |
| 09/13/2001 | WO2001066244A1 Materials with silicon-containing layers for use in miniaturized arrays and methods of manufacturing |
| 09/13/2001 | WO2001066243A2 Matrix reactor and a method for producing products in said reactor |
| 09/13/2001 | WO2001066242A2 Device and method for performing syntheses, analyses or transport processes |
| 09/13/2001 | WO2001066216A1 Method and system for rna analysis by matched ion polynucleotide chromatography |
| 09/13/2001 | WO2001066150A2 Highly efficient gene transfer into human repopulating stem cel ls by rd114 pseudotyped retroviral vector particles |
| 09/13/2001 | WO2001066149A2 Nucleic acid formulations for gene delivery and methods of use |
| 09/13/2001 | WO2001066148A1 A method of sensitising endothelial cells to prodrugs |
| 09/13/2001 | WO2001066134A1 Rfrp-containing prolactin secretion regulatory agent |
| 09/13/2001 | WO2001066131A1 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase |
| 09/13/2001 | WO2001066126A1 Sialoadhesin factor-2 antibodies |
| 09/13/2001 | WO2001066125A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4) |
| 09/13/2001 | WO2001066107A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | WO2001065928A1 A method for increasing the in vitro production of cystic embryoid bodies from mammalian embryonic stem cells |
| 09/13/2001 | WO2001065911A2 Improved poloxamer and poloxamine compositions for nucleic acid delivery |
| 09/13/2001 | WO2001036482A8 Transgenic mice expressing fluorescent protein under the control of the nestin promoter |
| 09/13/2001 | WO2001029178A3 Epo primary response gene 1, eprg1 |
| 09/13/2001 | WO2001027256A3 Chimeric transcriptional regulatory element and methods for prostate-targeted gene expression |
| 09/13/2001 | WO2001016328A3 Method for the production of regular nanostructures |
| 09/13/2001 | WO2001016288A3 Dna encoding the human serine protease c-e |
| 09/13/2001 | WO2001011010A3 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
| 09/13/2001 | WO2001009347A9 Archaeal replication accessory factors and methods of use |
| 09/13/2001 | WO2001009305A3 Purine metabolism genes in plants |
| 09/13/2001 | WO2001005480A3 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 09/13/2001 | WO2001004282A3 Replication-competent anti-cancer vectors |
| 09/13/2001 | WO2001003744A3 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of the c, d or v genes |